A process for manufacturing bulk solutions and lyophilized pure .alpha.-aztreonam lysinate for large scale production of an inhalable aztreonam is disclosed, as is a pure .alpha.-aztreonam lysinate for inhalation. A dry powder or lyophilized pure .alpha.-aztreonam lysinate composition for inhalation is also disclosed.

 
Web www.patentalert.com

> Vortex-enhanced filtration devices

~ 00302